Table 2.
The mucocutaneous findings of the patients.
| Mucocutaneous involvement, n (%) | 40 (93%) |
|---|---|
| Cutaneous involvement, n (%) | 35 (81.4%) |
| Cutaneous rash type, n (%) | |
| Urticarial lesions | 21 (48.8%) |
| Maculopapular | 11 (25.6%) |
| Livedoid rash | 5 (11.6%) |
| Pseudopernio | 1 (2.3%) |
| Cutaneous rash initiation site, n (%) | |
| Trunk | 14 (32.6%) |
| Palmoplantar | 9 (20.9%) |
| Lower extremity | 6 (14%) |
| Genital | 3 (7%) |
| Upper extremity | 2 (4.7%) |
| Face | 1 (2.3%) |
| Mucosal involvement, n (%) | 28 (65.1%) |
| Fissured lips | 12 (27.9%) |
| Cheilitis | 10 (23.3%) |
| Diffuse hyperemia of the oral mucosa | 8 (18.6%) |
| Strawberry tongue | 6 (13.9%) |
| Herpes labialis | 3 (6.9%) |
| Genital erosion | 0 |
| Eye involvement, n (%) | 28 (65.1%) |
| Conjunctival injection | 25 (58.1%) |
| Periorbital edema | 4 (9.3%) |
| Symmetrical edema of the hands and feet | 4 (9.3%) |
| Periungual desquamation, n (%) | 2 (4.7%) |